Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart Diseases

被引:5
|
作者
Benitez Ramos, Dunia Barbara [1 ]
Cabrera Ortega, Michel [2 ]
Castro Hevia, Jesus [3 ]
Dorantes Sanchez, Margarita [3 ]
Aleman Fernandez, Ailema Amelia [3 ]
Castaneda Chirino, Osmin [3 ]
Cruz Cardentey, Marlenis [3 ]
Martinez Lopez, Frank [3 ]
Falcon Rodriguez, Roylan [3 ]
机构
[1] Cardioctr Pediat William Soler, Dept Pediat Cardiol, San Francisco E-100 & Perla, Havana, Cuba
[2] Cardioctr Pediat William Soler, Sect Arrhythmia & Cardiac Pacing, 100 & Perla, Havana, Cuba
[3] Inst Cardiol & Cirugia Cardiovasc, Serv Arrhythmia & Cardiac Pacing, 17 & Paseo,Plaza Revoluc, Havana, Cuba
关键词
Electrocardiographic markers; Implantable cardioverter-defibrillator; Appropriate shocks; Congenital heart disease; FRAGMENTED QRS COMPLEX; SUDDEN CARDIAC DEATH; TORSADE-DE-POINTES; HIGH-RISK PATIENTS; LONG-QT SYNDROME; QUALITY-OF-LIFE; HYPERTROPHIC CARDIOMYOPATHY; T-WAVE; VENTRICULAR-TACHYCARDIA; REPAIRED TETRALOGY;
D O I
10.1007/s00246-017-1711-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Implantable cardioverter-defibrillators (ICDs) are increasingly utilized in patients with congenital heart disease (CHD). Prediction of the occurrence of shocks is important if improved patient selection is desired. The electrocardiogram (ECG) has been the first-line tool predicting the risk of sudden death, but data in CHD patients are lacking. We aim to evaluate the predictive value of electrocardiographic markers of appropriate therapy of ICD in young people with CHD. We conducted a prospective, longitudinal study, in twenty-six CHD patients (mean age 24.7 +/- 5.3 years) who underwent first ICD implantation. Forty-two age- and diagnosis-matched controls were recruited. Twelve-lead ECG and 24 h Holter analysis were performed during a mean follow-up of 38.9 months. Data included heart rate, heart rate variability, QRS duration (QRSd), QTc interval and its dispersion, Tpeak-Tend (Tp-Te) interval and its dispersion, presence of fragmented QRS (fQRS), T wave alternans, atrial arrhythmias, and non-sustained ventricular tachycardia. Implant indication was primary prevention in ten cases (38.5%) and secondary prevention in 16 (61.5%). Overall, 17 subjects (65.3%) received at least one appropriate and effective ICD discharge. fQRS was present in 64.7% of cases with ICD therapy compared with patients without events or controls (p < 0.0001). Tp-e and Tp-e dispersion were significantly prolonged in patients with recurrences (113.5 and 37.2 ms) versus patients without ICD discharge (89.6 and 24.1 ms) or controls (72.4 and 19.3 ms) (p < 0.0001 and p < 0.0001, respectively). On univariate Cox regression analysis QRSd (hazard ratio: 1.19 per ms, p = 0.003), QTc dispersion (hazard ratio: 1.57 per ms, p = 0.002), fQRS (hazard ratio: 3.58 p < 0.0001), Tp-e (hazard ratio: 2.27 per ms, p < 0.0001), and Tp-e dispersion (hazard ratio: 4.15 per ms, p < 0.0001), emerged as strong predictors of outcome. On multivariate Cox analysis fQRS, Tp-e and Tp-e dispersion remained in the model. The presence of fQRS, and both Tp-e and Tp-e dispersion are useful ECG tools in daily clinical practice to identify CHD patients at risk for appropriate ICD therapy.
引用
收藏
页码:1663 / 1671
页数:9
相关论文
共 50 条
  • [21] Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis
    Hamon, David
    Algalarrondo, Vincent
    Gandjbakhch, Estelle
    Extramiana, Fabrice
    Marijon, Eloi
    Elbaz, Nathalie
    Selhane, Dounia
    Dubois-Rande, Jean-Luc
    Teiger, Emmanuel
    Plante-Bordeneuve, Violaine
    Damy, Thibaud
    Lellouche, Nicolas
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 562 - 568
  • [22] RISK FACTORS FOR APPROPRIATE CARDIOVERTER-DEFIBRILLATOR SHOCKS, INAPPROPRIATE CARDIOVERTER-DEFIBRILLATOR SHOCKS, AND MORTALITY IN 549 PATIENTS WITH HEART FAILURE AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    Aronow, Wilbert S.
    Desai, Harit
    Gandhi, Kaushang
    Ahn, Chul
    Hussain, Sadaf
    Lai, Hoang M.
    Sharma, Mala
    Frishman, William H.
    Cohen, Martin
    Sorbera, Carmine
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [23] Implantable Cardioverter-Defibrillator Insertion in Congenital Heart Disease Without Transvenous Access to the Heart
    Nery, Pablo B.
    Green, Martin S.
    Khairy, Paul
    Alhebaishi, Yahya
    Hendry, Paul
    Birnie, David H.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (02) : 254.e1 - 254.e3
  • [24] Implantable cardioverter-defibrillator therapy in clinical practice
    Cesario, DA
    Dec, GW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) : 1507 - 1517
  • [25] Unresolved issues in implantable cardioverter-defibrillator therapy
    Mason, Pamela K.
    DiMarco, John P.
    CARDIOLOGY CLINICS, 2008, 26 (03) : 433 - +
  • [26] Clinical Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Adults With Congenital Heart Disease
    Moore, Jeremy P.
    Mondesert, Blandine
    Lloyd, Michael S.
    Cook, Stephen C.
    Zaidi, Ali N.
    Pass, Robert H.
    John, Anitha S.
    Fish, Frank A.
    Shannon, Kevin M.
    Aboulhosn, Jamil A.
    Khairy, Paul
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2016, 9 (09):
  • [27] Outcome of implantable cardioverter defibrillator therapy for congenital heart disease
    Uyeda, Tomomi
    Inoue, Kanki
    Sato, Junichiro
    Mizukami, Ayumi
    Yoshikawa, Tadahiro
    Wada, Naoki
    Ando, Makoto
    Takahashi, Yukihiro
    Umemura, Jun
    Park, In-Sam
    PEDIATRICS INTERNATIONAL, 2012, 54 (03) : 379 - 382
  • [28] FUTURE EXPECTATIONS OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY
    PRYSTOWSKY, EN
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1995, 18 (03): : 609 - 615
  • [29] VALUE OF PROPHYLACTIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY
    KUCK, KH
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1994, 17 (03): : 514 - 516
  • [30] Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort
    Ruwald, Martin H.
    Ruwald, Anne-Christine
    Johansen, Jens Brock
    Gislason, Gunnar
    Nielsen, Jens Cosedis
    Philbert, Berit
    Riahi, Sam
    Vinther, Michael
    Lindhardt, Tommi B.
    EUROPACE, 2019, 21 (08): : 1211 - 1219